Plant-Based Diet for Early Stage Multiple Myeloma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a plant-based diet can aid individuals who are overweight and have early-stage blood conditions like MGUS or SMM, which could progress to multiple myeloma, a type of cancer. The study will assess participants' adherence to the diet, its impact on weight loss, and its effects on overall quality of life. Additionally, it aims to determine if this diet can prevent the condition from worsening. Suitable candidates include those with a confirmed diagnosis of MGUS or SMM, a BMI of 25 or higher, and an interest in learning plant-based cooking. As an unphased trial, this study presents a unique opportunity to investigate lifestyle changes that could enhance health and prevent disease progression.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this plant-based diet is safe for participants?
Research has shown that a plant-based diet might be a safe choice for people at risk of developing multiple myeloma. Studies have found that consuming plant-based foods, such as beans, fruits, and vegetables, which are high in fiber, is linked to a lower risk of this condition. Thus, individuals who eat these foods may be less likely to develop multiple myeloma.
Additionally, past trials have suggested that a high-fiber plant-based diet could be beneficial for those at risk, supporting its safety and potential advantages. No evidence indicates serious harm from following a plant-based diet, making it a well-tolerated option for many.
Overall, the available research supports the safety of plant-based diets for people with early-stage conditions related to multiple myeloma, making it a promising choice for those seeking to manage their health through diet.12345Why are researchers excited about this trial?
Unlike the standard treatments for early stage multiple myeloma, which often involve chemotherapy, steroids, or immunotherapy, this new approach features a whole-foods plant-based diet. Researchers are excited because this diet emphasizes natural, nutrient-rich ingredients that could improve overall health without the side effects typically associated with drug therapies. Additionally, the inclusion of nutrition counseling offers personalized support, potentially enhancing adherence and effectiveness. This innovative approach might provide a gentler, more holistic way to manage the condition and improve patients' quality of life.
What evidence suggests that a plant-based diet is effective for early stage multiple myeloma?
Research suggests that a plant-based diet might slow the progression of conditions like MGUS and SMM to multiple myeloma. Studies have shown that people who primarily consume plants tend to have a lower risk of developing multiple myeloma compared to those who eat meat. A diet high in plant fiber might also benefit those at risk for this cancer type. Healthier eating habits, including more fruits, vegetables, and whole foods, have been linked to lower death rates in multiple myeloma patients. This trial will evaluate the effects of a plant-based diet, as participants will follow a whole-foods plant-based diet for 12 weeks, with nutrition counseling for 24 weeks. Increasing plant-based meals could be a promising way to manage these conditions.23567
Who Is on the Research Team?
Urvi A Shah, MD, MS
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for overweight adults with MGUS or SMM who have a BMI of 25 or higher, an M spike ≥0.2 g/dL, and are willing to learn plant-based cooking. Excluded are those with severe allergies, current participation in other studies or dietary programs, certain medical conditions as judged by the investigator, non-English speakers, and those already on vegan diets.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow a whole-foods plant-based diet with nutrition counselling
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Plant based meals
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor